Advisor Partners LLC Nektar Therapeutics Transaction History

Advisor Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 16, 2019	SELL	$16.91 - $36.27 $121,379 - $260,346	-7,178 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$31.0 - $36.3 $19,034 - $22,288	614 Added 9.35%	7,178 $255,000
Q1 2019 Apr 23, 2019	SELL	$31.58 - $46.35 $33,537 - $49,223	-1,062 Reduced 13.93%	6,564 $221,000
Q4 2018 Jan 29, 2019	BUY	$30.43 - $56.65 $76,135 - $141,738	2,502 Added 48.83%	7,626 $251,000
Q3 2018 Nov 06, 2018	BUY	$46.46 - $68.49 $418 - $616	9 Added 0.18%	5,124 $312,000

Q2 2018 Jul 25, 2018	SELL	$46.25 - $104.45 $36,676 - $82,828	-793 Reduced 13.42%	5,115 $250,000
Q1 2018 May 03, 2018	BUY	$57.4 - $108.44 $23,763 - $44,894	414 Added 7.54%	5,908 $628,000
Q4 2017 Jan 26, 2018	BUY	$23.02 - $60.5 $126,471 - $332,387	5,494	5,494 $393,000

126

109M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $259M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Advisor Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Advisor Partners LLC with notifications on news.